Hasil Pencarian - H. Dohner

  • Menampilkan 1 - 10 hasil dari 10
Perbaiki Hasil
  1. 1
    P556: CHANGES IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA RECEIVING IVOSIDENIB + AZACITIDINE OR PLACEBO + AZACITIDINE

    P556: CHANGES IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA RECEIVING IVOSIDENIB + AZACITIDINE OR PLACEBO + AZACITIDINE oleh A. Schuh, S. de Botton, C. Recher, S. Vives Polo, E. Zarzycka, J. Wang, G. Bertani, M. Heuser, R. Calado, S.-P. Yeh, J. Hui, S. Pandya, D. Gianolio, C. Chamberlain, H. Dohner, P. Montesinos

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    P470: NGS-BASED MINIMAL RESIDUAL DISEASE DETECTION IN PERIPHERAL BLOOD SHOWS GOOD PROGNOSTIC VALUE FOR OS AND EFS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECRUITED IN THE UNIFY TRIAL

    P470: NGS-BASED MINIMAL RESIDUAL DISEASE DETECTION IN PERIPHERAL BLOOD SHOWS GOOD PROGNOSTIC VALUE FOR OS AND EFS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA RECRUITED IN THE UNIFY TRI... oleh C. Thiede, C. Schuster, C. Krippendorf, G. Koenen, T. Medts, P. Marques Ramos, L. Gou, P. Montesinos, W. Fiedler, R. Müller, J. Krauter, S. Sica, J. Westermann, M. Levis, R. Stone, J. Sierra, H. Döhner

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    P430: MOLECULAR CHARACTERIZATION OF CLINICAL RESPONSE IN NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH IVOSIDENIB + AZACITIDINE COMPARED TO PLACEBO + AZACITIDINE

    P430: MOLECULAR CHARACTERIZATION OF CLINICAL RESPONSE IN NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH IVOSIDENIB + AZACITIDINE COMPARED TO PLACEBO + AZACITIDINE oleh S. de Botton, S. Choe, D. Marchione, P. Montesinos, C. Recher, S. Vives Polo, E. Zarzycka, J. Wang, G. Bertani, M. Heuser, R. Calado, A. Schuh, S.-P. Yeh, J. Hui, S. Pandya, D. Gianolio, S. Daigle, C. DiNardo, H. Dohner

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    P768: GUADECITABINE (SGI-110) VS. TREATMENT CHOICE (TC) IN RELAPSED/REFRACTORY(R/R) MYELODYSPLASTIC SYNDROME (MDS), RESULTS OF A GLOBAL, RANDOMIZED, PHASE 3 STUDY.

    P768: GUADECITABINE (SGI-110) VS. TREATMENT CHOICE (TC) IN RELAPSED/REFRACTORY(R/R) MYELODYSPLASTIC SYNDROME (MDS), RESULTS OF A GLOBAL, RANDOMIZED, PHASE 3 STUDY. oleh G. Garcia-Manero, S. Bart, J. K. McCloskey, P. Fenaux, D. Selleslag, G. Reda, D. Valcárcel, V. Santini, J. Mayer, B. Xicoy, H. Yamaguchi, M. Lübbert, Y. Miyazaki, H. Keer, Y. Hao, M. Azab, H. Döhner

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    P557: HEMATOLOGIC IMPROVEMENTS WITH IVOSIDENIB + AZACITIDINE COMPARED WITH PLACEBO + AZACITIDINE IN PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA

    P557: HEMATOLOGIC IMPROVEMENTS WITH IVOSIDENIB + AZACITIDINE COMPARED WITH PLACEBO + AZACITIDINE IN PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA oleh H. Dohner, P. Montesinos, S. Vives Polo, E. Zarzycka, J. Wang, G. Bertani, M. Heuser, R. Calado, A. Schuh, S.-P. Yeh, A. de la Fuente, C. Cerchione, S. Daigle, J. Hui, S. Pandya, D. Gianolio, C. Recher, S. de Botton

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    P498: CLINICAL AND BIOLOGICAL MARKERS ASSOCIATED WITH LONG-TERM SURVIVAL FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN REMISSION AFTER CHEMOTHERAPY IN THE QUAZAR AML-001 TRIAL OF ORAL AZACITIDINE

    P498: CLINICAL AND BIOLOGICAL MARKERS ASSOCIATED WITH LONG-TERM SURVIVAL FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN REMISSION AFTER CHEMOTHERAPY IN THE QUAZAR AML-001 TRIAL... oleh A. H. Wei, H. Döhner, H. Sayar, F. Ravandi, P. Montesinos, H. Dombret, D. Selleslag, K. Porkka, J.-H. Jang, B. Skikne, C. Beach, T. Prebet, G. Zhang, A. Risueño, M. Ugidos Guerrero, W. L. See, D. Menezes, G. J. Roboz

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Randomized phase-III study of low-dose cytarabine and etoposide + /− all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia

    Randomized phase-III study of low-dose cytarabine and etoposide + /− all-trans retinoic acid in older unfit patients with NPM1-mutated acute myeloid leukemia oleh R. F. Schlenk, D. Weber, J. Krzykalla, T. Kindler, G. Wulf, B. Hertenstein, H. R. Salih, T. Südhoff, J. Krauter, U. Martens, S. Wessendorf, V. Runde, H. J. Tischler, M. Bentz, E. Koller, M. Heuser, F. Thol, A. Benner, A. Ganser, K. Döhner, H. Döhner

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    P1055: CLINICAL AND GENETIC RESULTS OF THE PHASE IB/II TRIAL MPNSG-0212: RUXOLITINIB PLUS POMALIDOMIDE IN MYELOFIBROSIS WITH ANEMIA

    P1055: CLINICAL AND GENETIC RESULTS OF THE PHASE IB/II TRIAL MPNSG-0212: RUXOLITINIB PLUS POMALIDOMIDE IN MYELOFIBROSIS WITH ANEMIA oleh F. Stegelmann, E. Jahn, S. Koschmieder, F. Heidel, A. Hochhaus, H. Hebart, S. Isfort, A. Reiter, M. Bangerter, C. F. Waller, D. Wolleschak, C. Scheid, J. Göthert, P. Schafhausen, T. Kindler, M. P. Radsak, N. Gattermann, R. Möhle, N. von Bubnoff, A. Schrade, T. Brümmendorf, H. Döhner, M. Griesshammer, K. Döhner

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    P448: PROGNOSTIC IMPACT OF SOMATIC CEBPA BZIP DOMAIN MUTATIONS IN ACUTE MYELOID LEUKEMIA

    P448: PROGNOSTIC IMPACT OF SOMATIC CEBPA BZIP DOMAIN MUTATIONS IN ACUTE MYELOID LEUKEMIA oleh F. G. Ruecker, A. Corbacioglu, F. Theis, M. Christopeit, U. Germing, G. Wulf, M. Abu Samra, L. Teichmann, M. Lübbert, M. W. Kühn, M. Bentz, J. Westermann, L. Bullinger, V. I. Gaidzik, E. Jahn, M. Gröger, S. Kapp-Schwoerer, D. Weber, F. Thol, M. Heuser, A. Ganser, H. Döhner, K. Döhner

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    S130: NPM1 MUTATED AML: IMPACT OF CO-MUTATIONAL PATTERNS - RESULTS OF THE EUROPEAN HARMONY ALLIANCE

    S130: NPM1 MUTATED AML: IMPACT OF CO-MUTATIONAL PATTERNS - RESULTS OF THE EUROPEAN HARMONY ALLIANCE oleh A. Hernández-Sánchez, Á. Villaverde-Ramiro, J. Martínez Elicegui, T. González, A. Benner, E. Sträng, G. Castellani, C. A. Heckman, J. Versluis, M. Abáigar, M. Sobas, R. Azibeiro, L. Tur, P. J. Valk, K. H. Metzeler, R. Ayala, D. Dall’Olio, J. Tettero, J. Martínez-López, H. Dombret, M. Pratcorona, F. Damm, K. I. Mills, J. Mayer, C. Thiede, M. T. Voso, G. F. Sanz, F. Calado, K. Döhner, V. I. Gaidzik, M. Heuser, T. Haferlach, A. T. Turki, D. Reinhardt, R. Villoria Medina, M. van Speybroeck, R. Schulze-Rath, M. Barbus, J. E. Butler, J. M. Hernández Rivas, B. J. Huntly, G. J. Ossenkoppele, H. Döhner, L. Bullinger

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: